ANTIENDOTOXIN MONOCLONAL-ANTIBODIES - A 2ND LOOK

被引：123

作者：

WENZEL, RP

机构：

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1992年 / 326卷 / 17期

关键词：

D O I：

10.1056/NEJM199204233261710

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1151 / 1153

页数：3

共 13 条

[1] SEPSIS SYNDROME - A VALID CLINICAL ENTITY [J].

BONE, RC ;

FISHER, CJ ;

CLEMMER, TP ;

SLOTMAN, GJ ;

METZ, CA ;

BALK, RA .

CRITICAL CARE MEDICINE, 1989, 17 (05) :389-393

[2]

BRYAN CS, 1983, REV INFECT DIS, V5, P629

[3] A CONTROLLED CLINICAL-TRIAL OF E5 MURINE MONOCLONAL IGM ANTIBODY TO ENDOTOXIN IN THE TREATMENT OF GRAM-NEGATIVE SEPSIS [J].

GREENMAN, RL ;

SCHEIN, RMH ;

MARTIN, MA ;

WENZEL, RP ;

MACINTYRE, NR ;

EMMANUEL, G ;

CHMEL, H ;

KOHLER, RB ;

MCCARTHY, M ;

PLOUFFE, J ;

RUSSELL, JA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (08) :1097-1102

[4] GRAM-NEGATIVE BACTEREMIA .4. RE-EVALUATION OF CLINICAL-FEATURES AND TREATMENT IN 612 PATIENTS [J].

KREGER, BE ;

CRAVEN, DE ;

MCCABE, WR .

AMERICAN JOURNAL OF MEDICINE, 1980, 68 (03) :344-355

[5]

KUNIN CM, 1990, PRINCIPLES PRACTICE, P427

[6] COST-EFFECTIVENESS OF HA-1A MONOCLONAL-ANTIBODY FOR GRAM-NEGATIVE SEPSIS - ECONOMIC-ASSESSMENT OF A NEW THERAPEUTIC AGENT [J].

SCHULMAN, KA ;

GLICK, HA ;

RUBIN, H ;

EISENBERG, JM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (24) :3466-3471

[7]

WARREN HS, 1992, NEW ENGL J MED, V326, P1153, DOI 10.1056/NEJM199204233261711

[8]

WENZEL R, 1991, 31ST INT C ANT AG CH, P294

[9] THE MORTALITY OF HOSPITAL-ACQUIRED BLOOD-STREAM INFECTIONS - NEED FOR A NEW VITAL STATISTIC [J].

WENZEL, RP .

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1988, 17 (01) :225-227

[10] ANTIENDOTOXIN MONOCLONAL-ANTIBODIES FOR GRAM-NEGATIVE SEPSIS - GUIDELINES FROM THE IDSA [J].

WENZEL, RP ;

ANDRIOLE, VT ;

BARTLETT, JG ;

BATT, MD ;

BULLOCK, WE ;

COBBS, CG ;

LIGHT, B ;

MARTIN, MA ;

SANFORD, J ;

SANDE, MA .

CLINICAL INFECTIOUS DISEASES, 1992, 14 (04) :973-976

← 1 2 →